CAXEM

Welcome to the Brand page for “CAXEM”, which is offered here for Pharmaceutical research and development in the field of cardiovascular disease, in particular, hyperlipidemia;.

Its status is currently believed to be active. Its class is unavailable. “CAXEM” is believed to be currently owned by “Aegerion Pharmaceuticals, Inc.”